We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
National Resilience, Inc., said that the Government of Canada will invest $163.8 million, through the Strategic Innovation Fund, in the company’s Ontario-based subsidiary Resilience Biotechnologies Inc. (RBI) to modernize and expand production capacity.
National Resilience, Inc., a company that says it is building a biopharmaceutical manufacturing ecosystem, has acquired Ology Bioservices, a privately held company that also specializes in biologic drug substance manufacturing from early stage ...